Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
429.00    -0.20 (-0.05%)
Bid:
427.90
Ask:
428.10
Spread: 0.20 (0.047%)
Market Cap: £10.79b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Directorate Change

6 Nov 2017 07:00

RNS Number : 5632V
Rentokil Initial PLC
06 November 2017
Β 

6 November 2017

Β 

Appointment of Non-Executive Director

Β 

Rentokil Initial plc (FTSE: RTO, "the Company") today announces the appointment of John Pettigrew to its Board as a Non-Executive Director with effect from 1 January 2018. John will also become a member of the Audit Committee and the Nomination Committee from this date.

Β 

John is Chief Executive of National Grid plc, a FTSE 20 company. He joined National Grid in 1991 and progressed through a variety of roles before joining the Board as UK Executive Director in April 2014. He was appointed Chief Executive in April 2016. He has over 25 years of experience at National Grid in a variety of senior management roles, including Director of Engineering in the UK, Chief Operating Officer and Executive Vice President for the US Electricity Distribution & Generation business, Chief Operating Officer for UK Gas Distribution and UK Chief Operating Officer from 2012 to 2014.Β 

Β 

Prior to his appointment as Chief Executive of National Grid, John served on the UK Electricity and Gas licence entity boards. He was a Director for National Grid Electricity Transmission plc from September 2012 and of National Grid Gas plc from April 2011, becoming Chairman of both in 2015.

Β 

John is a Fellow of the Energy Institute and of the Institution of Energy and Technology. He holds a BSc in Economics and an MSc in International Economics and Banking. He also completed the Advanced Management Program at Harvard Business School in 2010.

Β 

Commenting on the appointment, John McAdam, Chairman of Rentokil Initial, said:

Β 

"We are delighted to welcome John to the Board of Rentokil Initial. His international experience of developing and implementing strategies for profitable growth, and in leading a business with a large field-based workforce, will be very valuable in the Company's continued development."Β 

Β 

There are no further details to be disclosed relating to John Pettigrew under Section 9.6.13 of the Listing Rules.

Β 

Β 

For further information please contact:

Β 

Rentokil Initial plc

Media

Malcolm Padley

07788 978199

Company Secretary

Daragh Fagan

01276 607444

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOAUGGCCGUPMGCW
Date   Source Headline
28th Jul 20253:00 pmRNSHolding(s) in Company
10th Jul 202511:00 amRNSHolding(s) in Company
1st Jul 202510:25 amRNSTotal Voting Rights
10th Jun 202510:05 amRNSAdditional Listing
3rd Jun 20254:00 pmRNSDirector/PDMR Shareholding
28th May 20257:00 amRNSSale of France Workwear
19th May 20252:30 pmRNSDirector/PDMR Shareholding
7th May 20254:15 pmRNSResult of AGM
7th May 20257:01 amRNSDirectorate Change: Appointment of NEDs
7th May 20257:00 amRNSDirectorate Change: Chief Executive to retire
28th Apr 20252:30 pmRNSIssue of Debt
17th Apr 20252:20 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 Trading Update
9th Apr 202510:25 amRNSHolding(s) in Company
1st Apr 20252:15 pmRNSNotice of Q1 Trading Update and Management Call
1st Apr 202510:25 amRNSBlock listing Interim Review
27th Mar 202510:25 amRNSDirector/PDMR Shareholding
26th Mar 202510:30 amRNSAnnual Financial Report
14th Mar 202510:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
28th Jan 20257:00 amRNSTrading Update (unaudited)
14th Jan 202511:15 amRNSHolding(s) in Company
13th Jan 202511:15 amRNSHolding(s) in Company
13th Dec 20249:30 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSDirectorate Change
12th Nov 202410:30 amRNSHolding(s) in Company
8th Nov 202410:30 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSQ3 Trading Update
1st Oct 20242:00 pmRNSBlock listing Interim Review
25th Sep 20247:00 amRNSAppointment of Non-Executive Director
19th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSTrading Update
10th Sep 202410:30 amRNSHolding(s) in Company
5th Sep 202411:08 amRNSHolding(s) in Company
25th Jul 20247:00 amRNS2024 Interim Results
10th Jul 20244:35 pmRNSHolding(s) in Company
26th Jun 20245:12 pmRNSDirector/PDMR Shareholding
26th Jun 202411:08 amRNSHolding(s) in Company
17th May 20243:30 pmRNSDirector/PDMR Shareholding
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.